Cargando…
Taking Bacteriophage Therapy Seriously: A Moral Argument
The excessive and improper use of antibiotics has led to an increasing incidence of bacterial resistance. In Europe the yearly number of infections caused by multidrug resistant bacteria is more than 400.000, each year resulting in 25.000 attributable deaths. Few new antibiotics are in the pipeline...
Autores principales: | Verbeken, Gilbert, Huys, Isabelle, Pirnay, Jean-Paul, Jennes, Serge, Chanishvili, Nina, Scheres, Jacques, Górski, Andrzej, De Vos, Daniel, Ceulemans, Carl |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020481/ https://www.ncbi.nlm.nih.gov/pubmed/24868534 http://dx.doi.org/10.1155/2014/621316 |
Ejemplares similares
-
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
por: Verbeken, Gilbert, et al.
Publicado: (2014) -
Business oriented EU human cell and tissue product legislation will adversely impact Member States’ health care systems
por: Pirnay, Jean-Paul, et al.
Publicado: (2013) -
Stability of bacteriophages in burn wound care products
por: Merabishvili, Maia, et al.
Publicado: (2017) -
Selection and Characterization of a Candidate Therapeutic Bacteriophage That Lyses the Escherichia coli O104:H4 Strain from the 2011 Outbreak in Germany
por: Merabishvili, Maia, et al.
Publicado: (2012) -
Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials
por: Merabishvili, Maya, et al.
Publicado: (2009)